Compared with the control group, proliferation, migration, and invasion of glioma cells decreased in agomiR-627-5p+NR2C2(−) group (P < 0.05), but increased in antagomiR-627-5p+NR2C2(+) group (Fig. 6a, b, P < 0.01). This evidence concerns the gene NR2C2 and glioma.